ABSI vs. CLBT
ABSI (Absci Corporation) and CLBT (Cellebrite DI Ltd.) are both stocks. ABSI operates in Biotechnology (Healthcare), while CLBT operates in Software - Infrastructure (Technology). Over the past 3 years, ABSI returned 50.04%/yr vs 37.92%/yr for CLBT. At a 0.25 correlation, their price movements are largely independent.
Performance
ABSI vs. CLBT - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ABSI achieves a 81.95% return, which is significantly higher than CLBT's -16.92% return.
ABSI
- 1D
- -2.61%
- 1M
- 29.07%
- YTD
- 81.95%
- 6M
- 109.57%
- 1Y
- 132.60%
- 3Y*
- 50.04%
- 5Y*
- —
- 10Y*
- —
CLBT
- 1D
- -5.61%
- 1M
- 12.21%
- YTD
- -16.92%
- 6M
- -15.89%
- 1Y
- -8.38%
- 3Y*
- 37.92%
- 5Y*
- —
- 10Y*
- —
ABSI vs. CLBT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
ABSI Absci Corporation | 81.95% | 33.21% | -37.62% | 100.00% | -74.39% | -56.34% |
CLBT Cellebrite DI Ltd. | -16.92% | -18.16% | 154.39% | 98.62% | -45.64% | -21.76% |
Correlation
The correlation between ABSI and CLBT is 0.20, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.20 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.26 |
Correlation (All Time) Calculated using the full available price history since Sep 1, 2021 | 0.25 |
Fundamentals
ABSI:
$971.31M
CLBT:
$3.78B
ABSI:
-$0.82
CLBT:
$0.29
ABSI:
563.05
CLBT:
7.56
ABSI:
5.65
CLBT:
7.40
ABSI:
$1.62M
CLBT:
$496.43M
ABSI:
-$21.67M
CLBT:
$416.33M
ABSI:
-$115.23M
CLBT:
$84.98M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ABSI vs. CLBT — Risk / Return Rank
ABSI
CLBT
ABSI vs. CLBT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Absci Corporation (ABSI) and Cellebrite DI Ltd. (CLBT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ABSI | CLBT | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.43 | -0.16 | +1.60 |
Sortino ratioReturn per unit of downside risk | 2.28 | 0.12 | +2.15 |
Omega ratioGain probability vs. loss probability | 1.27 | 1.01 | +0.26 |
Calmar ratioReturn relative to maximum drawdown | 2.59 | -0.23 | +2.82 |
Martin ratioReturn relative to average drawdown | 4.76 | -0.52 | +5.28 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| ABSI | CLBT | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.43 | -0.16 | +1.60 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.23 | 0.17 | -0.40 |
Drawdowns
ABSI vs. CLBT - Drawdown Comparison
The maximum ABSI drawdown since its inception was -96.20%, which is greater than CLBT's maximum drawdown of -67.74%. Use the drawdown chart below to compare losses from any high point for ABSI and CLBT.
Loading charts...
Drawdown Indicators
| ABSI | CLBT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -96.20% | -67.74% | -28.46% |
Max Drawdown (1Y)Largest decline over 1 year | -54.00% | -43.61% | -10.39% |
Max Drawdown (3Y)Largest decline over 3 years | -66.06% | -57.58% | -8.48% |
Current DrawdownCurrent decline from peak | -79.04% | -42.38% | -36.66% |
Average DrawdownAverage peak-to-trough decline | -84.81% | -34.47% | -50.34% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 29.31% | 19.55% | +9.76% |
Volatility
ABSI vs. CLBT - Volatility Comparison
Absci Corporation (ABSI) has a higher volatility of 30.14% compared to Cellebrite DI Ltd. (CLBT) at 20.75%. This indicates that ABSI's price experiences larger fluctuations and is considered to be riskier than CLBT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ABSI | CLBT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 30.14% | 20.75% | +9.39% |
Volatility (6M)Calculated over the trailing 6-month period | 65.23% | 39.81% | +25.42% |
Volatility (1Y)Calculated over the trailing 1-year period | 93.03% | 51.31% | +41.72% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 96.52% | 50.33% | +46.19% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 96.52% | 50.33% | +46.19% |
Dividends
ABSI vs. CLBT - Dividend Comparison
Neither ABSI nor CLBT has paid dividends to shareholders.
Financials
ABSI vs. CLBT - Financials Comparison
This section allows you to compare key financial metrics between Absci Corporation and Cellebrite DI Ltd.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ABSI and CLBT have a correlation of 0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ABSI has higher volatility (30.14%) compared to CLBT (20.75%). In terms of maximum drawdown, ABSI dropped -96.20% vs CLBT's -67.74%.
ABSI currently has the higher Sharpe Ratio (1.43 vs -0.16), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ABSI and CLBT
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer